EUCTR2013-003932-56-FI进行中（未招募）1 期
ESPAC-5F: European Study Group for Pancreatic Cancer - Trial 5F Four arm, prospective, multicentre, randomised feasibility trial of immediate surgery compared with neoadjuvant chemotherapies and neoadjuvant chemoradiotherapy. - ESPAC-5F
niversity of Liverpool0 个研究点目标入组 90 人开始时间: 2017年8月29日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 90
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Histopathologically confirmed borderline resectable pancreatic
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 5
排除标准
- •Severe comorbidity, inadequate organ function, performance status over
研究者
相似试验
进行中（未招募）
1 期
ESPAC-5F: European Study Group for Pancreatic Cancer - Trial 5FBorderline resectable pancreatic cancerEUCTR2013-003932-56-DEniversity of Liverpool90
进行中（未招募）
1 期
ESPAC-5F: European Study Group for Pancreatic Cancer-Trial 5FBorderline resectable pancreatic cancer.MedDRA version: 19.0Level: LLTClassification code 10033608Term: Pancreatic cancer resectableSystem Organ Class: 100000004864EUCTR2013-003932-56-IEniversity of Liverpool100
进行中（未招募）
不适用
ESPAC-5F: European Study Group for Pancreatic Cancer - Trial 5FEUCTR2013-003932-56-GBniversity of Liverpool100
已完成
3 期
A trial comparing gemcitabine alone with gemcitabine and capecitabine together after surgery to remove cancer of the pancreasPancreatic cancerCancerISRCTN96397434niversity of Liverpool and the Royal Liverpool and Broadgreen University Hospital NHS Trust (UK)730
已完成
不适用
ESPAC-5: European Study group for Pancreatic Cancer - Trial 5Topic: CancerSubtopic: Upper Gastro-Intestinal CancerDisease: PancreasCancerISRCTN89500674niversity of Liverpool (UK)90